Companies · Medical Devices
Africa · Medical Devices
Diligence memoA one-page analyst read on Ilara Health — recommendation, valuation, rhythm, risks.→Ilara Health looks under-valued against its niche peers and is dormant on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the medical devices sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Ilara Health is one of 233 Medical Devices companies tracked from Africa. By capital raised it ranks in the long tail (ahead of 36% of sector peers), and mid-pack by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
Kenyan startup Ilara Health, which is bringing affordable diagnostics services to doctors, has raised a US$735,000 seed funding round.
Kenyan startup Ilara Health, which is bringing affordable diagnostics services to doctors, has raised a US$735,000 seed funding round.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.
Round size and date are reported; the stage label is inferred from round size (latest is Seed — a $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the medical devices sector profile. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 233 companies in Medical Devices. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 36% of sector peers (real $). Modeled value above 62% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #21 of 23.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Gradian Diagnostics Inc | Seed | $3.1M | $92.3M | 2.21× |
| Regent Surgical Health Intermediate Holdings, Inc. | Seed | $4.0M | $86.5M | 2.07× |
| Caliber Imaging & Diagnostics, Inc. | Seed | $2.8M | $82.6M | 1.97× |
| Dxterity Diagnostics Inc | Seed | $8.7M | $77.0M | 1.84× |
| Sure Count Surgical, LLC | Seed | $2.5M | $73.5M | 1.76× |
| Preventric Diagnostics, LLC | Seed | $2.3M | $66.7M | 1.59× |
| Kantum Diagnostics, Inc. | Seed | $5.3M | $65.7M | 1.57× |
| Kahtnu Surgical, Inc. | Seed | $2.3M | $63.8M | 1.53× |
| Surgical Suites of Coastal Virginia, LLC | Seed | $1.9M | $56.6M | 1.35× |
| Alea Diagnostics, Inc. | Seed | $2.0M | $56.3M | 1.35× |
| Biovision Diagnostics LLC | Seed | $2.3M | $47.6M | 1.14× |
| Freedom For All Diagnostics, Inc. | Seed | $2.5M | $41.8M | 1.00× |
| Ilara Health this company | Seed | $735K | $21.8M | 0.52× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Seed | $735K | 2019-08-08 | $3.7M | $21.8M | 45% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Ilara Health is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Legacy Surgical Holding, LLC | Medical Devices | Seed | $1.0M | $30.7M | same sector · same stage |
| SafeGuard Surgical, Inc. | Medical Devices | Seed | $1.1M | $5.9M | same sector · same stage |
| Intu Diagnostics | Medical Devices | Seed | $1.2M | $2.2M | same sector · same stage |
| Nashville Midtown Surgical, LLC | Medical Devices | Seed | $1.2M | $35.5M | same sector · same stage |
| Aultman North Surgical Partners, LLC | Medical Devices | Seed | $1.5M | $8.2M | same sector · same stage |
| Fera Diagnostics & Biologicals Corp. | Medical Devices | Seed | $1.5M | $34.0M | same sector · same stage |
| ACES Diagnostics, Inc. | Medical Devices | Seed | $1.6M | $7.3M | same sector · same stage |
| Strauss Surgical USA LLC | Medical Devices | Seed | $1.6M | $7.9M | same sector · same stage |
See where Ilara Health sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Ilara Health, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.